US › Healthcare

Scribe Therapeutics Inc. Common Stock (SCTX)

US · Healthcare · Biotechnology

$32.14+10.45%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.9M

Net profit

$-6.5M

EPS

$-3.84

EPS estimate

$-6.20

Net margin

-337.7%

EPS came in at -3.84 against a street estimate of -6.20 — a beat of 38.1%.

Key statistics

Market cap

$550.9M

Forward P/E

0.0

P/B

0.00

Book value

$-64.31

EPS (TTM)

$-1.69

52-week high

$39.60

52-week low

$15.00

50-day MA

$26.68

200-day MA

$26.68

Analyst view

with an average price target of $57.00.

Shareholding

Insiders

10.70%

Institutions

51.02%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scribe Therapeutics Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.